BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1570714)

  • 21. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
    Ito M; Imoto S; Nakagawa T; Kai S; Hara H
    Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.
    De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma exchange for removal of anti-A and anti-B group antibodies in AB0 major-incompatible bone marrow transplantation.
    Haustein B; Achenbach H; Weissflog A; Kubel M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):463-7. PubMed ID: 2480291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.
    Franchini M; Gandini G; Aprili G
    Bone Marrow Transplant; 2004 Jun; 33(12):1169-72. PubMed ID: 15094753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants.
    Mehta P; Ramprakash S; Raghuram CP; Trivedi D; Dhanya R; Agarwal RK; Faulkner L
    Ann Hematol; 2021 Aug; 100(8):2071-2078. PubMed ID: 34148110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow.
    Ho WG; Champlin RE; Feig SA; Gale RP
    Br J Haematol; 1984 May; 57(1):155-62. PubMed ID: 6372850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double buffy coat method for red cell removal from ABO-incompatible marrow.
    Rosenfeld CS; Tedrow H; Boegel F; Gremba C; Shadduck RK
    Transfusion; 1989 Jun; 29(5):415-7. PubMed ID: 2660336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABO-incompatible pediatric bone marrow transplantation: a simple method to remove red blood cells from small volume marrow grafts.
    Chan KW; Herd SL; Stanley CE; Wadsworth LD
    Bone Marrow Transplant; 1991 Dec; 8(6):473-6. PubMed ID: 1790427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infusion hemolysis after pediatric major ABO-mismatched bone marrow transplant: Comparison of two red blood cell depletion techniques.
    Nickel RS; Qayed M; Worthington-White D; Stowell SR; Chiang KY
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow.
    Schanz U; Gmür J
    Bone Marrow Transplant; 1992 Dec; 10(6):507-13. PubMed ID: 1490200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature.
    Raimondi R; Soli M; Lamparelli T; Bacigalupo A; Arcese W; Belloni M; Rodeghiero F;
    Bone Marrow Transplant; 2004 Aug; 34(4):321-9. PubMed ID: 15235580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple technique for red blood cell removal in major ABO-incompatible bone marrow transplantation.
    Mayer G; Wernet D; Northoff H; Schneider W
    Vox Sang; 1994; 66(2):112-6. PubMed ID: 8184592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ABO-major incompatible bone marrow transplantation. Experiences with a simple method for the preparation of erythrocyte-poor bone marrow].
    Mayer G; Wernet D; Schneider W; Hanfland P
    Beitr Infusionsther; 1990; 26():205-7. PubMed ID: 1703831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.